Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin vs Sham in Acute BRVO
NCT00370851Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in branch retinal vein occlusion (BRVO), sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT00370851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370851.